|
East and Central African Journal of Surgery
Association of Surgeons of East Africa and College of Surgeons of East Central and Southern Africa
ISSN: 1024-297X EISSN: 2073-9990
Vol. 9, Num. 2, 2004, pp. 72-73
|
East and Central African Journal of Surgery, Vol. 9, No. 2, Dec, 2004, pp. 72-73
Aspergillus of the Lung with Haemoptysis: A surgical emergency
Mohamed Yusuf Hassan1 MD, Marco Baldan2 MD
1Consultant Surgeon Medina Hospital, Mogadishu Somalia, 2Regional Surgeon, ICRC, Nairobi Kenya.
Code Number: js04043
Background: Aspegillus is an important pathogen in patients with impaired host defences. These mycelial fungi can cause local as well disseminated disease. Two forms of pulmonary aspergillosis are frequently seen : 1. pulmonary or brochial aspergilloma (fungus ball) due to secondary invasion of a a tuberculous cavity and 2. allergic bronchopulmonary aspergilosis. The aim study was to evaluate the outcome of surgical management in patients with Aspergillomas of the lung with recurrent and severe Haemoptysis.
Methods: Eight patients were treated surgically for Aspergillomas of the lung; six of them in Maputo Central Hospital and the other two in Medina Hospital in Somalia. These Aspergillums lesions were located in the upper lobe as a fungal ball. In five of the patients the lesions were located in the right upper lobe while in the other three the left upper lobe was involved. In Maputo Central Hospital, investigations done in all six patients included the plain chest X-rays, CT scans, bronchoscopy and common laboratory exams. The two patients in Medina Hospital had only plain X-rays and common laboratory exams. All the eight patients had upper lobectomy. No intrathoracic contamination occurred during surgery.
Results: Eight patients with recurrent and severe Haemoptysis had surgical treatment (upper lobectomies) without intrathoracic contamination. All the patients had an average of ten days of postoperative hospital.
Complications:One patient has died for postoperative haemorrhage among those patients treated in Maputo Central Hospital.
Conclusion: Our limited experience of 8 patients showed that surgical treatment is effective and leads to a complete recovery and rehabilitation of the patient
Introduction
Aspergilloma is the most common and bestrecognized
form of pulmonary involvement by
Aspergillus The aspergilloma (fungal ball)
consists of masses of fungal mycelia,
inflammatory cells, fibrin, mucus and tissue
debris, usually developing in a preformed lung
cavity. Although other fungi may cause the
formation of the fungal ball such as
Zygomycetes and Fusarium. Aspergillus spp
(specifically, A. fumigatus) are by far the most
common etiologic agents.
Patients and Methods
The cases studied included eight patients who
had been treated surgically for Aspergillums of
the lung; six of them in Maputo Central Hospital
and the remaining two in Medina Hospital. Of
the 8 patients 2 were female and 6 were male,
aged between 22 – 38 years old, mean age is 30
years old. The most complained of symptoms
with massive Haemoptysis and a dyspnoea. The
six patients from Maputo Central Hospital
among them the two females were referred by
the pneumology ward of the same hospital and
all had a history of treatment for tuberculosis.
The six patients had all possible investigations
including chest X-rays, CT-scan, bronchoscopy
and the required common laboratory tests. Chest
radiographs showed cavities with fungal balls in
the upper lobes.
The 2 patients from Medina Hospital had only
plain chest X-rays which confirmed the
presence of apical cavities with fungal balls.
The cavities were located: in the right upper
lobe in five and in the left upper lobe in three
patients respectively.
Results
All eight patients with recurrent and severe
haemoptysis had upper lobectomy. During
surgery, adhesions of the upper lobe to the chest
wall were carefully removed. Single ligation and
division of the hilar elements was performed
avoiding intrapleural spillage and cavity
contamination. Seven of the patients stayed in
the hospital for not more than 10 days and had
fully recovered on discharge. They were able to
return to normal routine activities. In these
patients, the aspergilloma was confined to the
apical lobes and therefore they were good
candidates for surgery. One patients among those treated in Maputo Central Hospital died of
severe postoperative haemorrhage.
Discussion
The true incidence of aspergilloma is unknown. In a study of 544 patients with pulmonary cavities secondary to tuberculosis, 11% had radiologic evidence of aspergilloma. The most common predisposing factor was the presence of a pre-existing lung cavity formed secondary to tuberculosis, sarcoidosis, bronchiectasis or bronchial cysts1. Of these, tuberculosis is the most frequently associated condition as observed in our cases.
Occasionally aspergilloma might be described in cavities caused by other fungal infections. It is believed that inadequate drainage facilitates the growth of Aspergillus on the walls of these cavities. Usually, the fungus does not invade the surrounding lung parenchyma or blood vessels; exceptions, however, have been noted. The natural history of aspergilloma is variable. In the majority of cases, the lesion remains stable, however, in approximately 10% of cases it may decrease in size or resolve spontaneously without treatment. Rarely, the aspergilloma increases in size.
An aspergilloma may exist for years without causing symptoms. Most patients will experience mild haemoptysis, but severe haemoptysis may occur, particularly in patients with underlying tuberculosis. Bleeding usually occurs from bronchial blood vessels lining the cavity, endotoxins released by the fungus with haemolytic properties, and mechanical friction of the aspergilloma with the cavity wall blood vessels. The cough and dyspnea are probably more related to the underlying lung disease. Fever is rare unless there is a secondary bacterial infection.
Whenever massive and severe haemoptysis starts, there should be delay with a prolonged observation and conservative treatment in the cases where aspergilloma is resectable and the remaining lung has a good predictable function. Surgery is the best choice as aspergilloma treatment.
References
- Soubani: “The Clinical Spectrum of Pulmonary Aspergillosis” Chest, Volume 121(6). June 2002
- Roberts CM, Citron KM, Strickland B. Intrathoracic aspergilloma: role of CT in diagnosis and treatment. Radiology 1987 165: 123-128
- Bandoh S, Fujita J, Fukunaga Y, et al. Cavitary lung cancer with an aspergilloma-like shadow. Lung Cancer 1999; 26:195-198
- Le Thi HD, Wechsler B, Chamuzeau JP, et al. Pulmonary aspergilloma complicating Wegner’s granulomatosis [letter]. Scand J Rheumatol 1995; 24:260
- McCarthy DS, Pepys J. Pulmonary aspergilloma: clinical immunology. Clin allergy 1973; 3:57-70
- Pennington JE. Aspergilloma lung disease. Med Clin North Am 1980; 64:475-490
- Yamada H, Kohno S, Koga H, et al. Topical treatment of pulmonary aspergilloma by antifungals: relationship between duration of the disease and efficacy of therapy. Chest 1993;
103:1421-1425.
- Munk PL, Vellet AD, Rankin RN et al. Interactivity aspergilloma: transthoracic percutaneous injection of amphotercin gelatine solution, Radiology 1993; 188:821 – 823.
© 2004 East and Central African Journal of Surgery
|